Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature

With the introduction of safe and effective factor VIII/IX‐bypassing agents – recombinant activated factor VII (rFVIIa) and plasma‐derived activated prothrombin complex concentrates (pd‐APCC) – elective orthopaedic surgery (EOS) is a viable option for haemophilia patients with inhibitors. We report...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2011-11, Vol.17 (6), p.910-919
Hauptverfasser:	CAVIGLIA, H., CANDELA, M., GALATRO, G., NEME, D., MORETTI, N., BIANCO, R. P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Blood Coagulation Factor Inhibitors Blood Coagulation Factors - therapeutic use Blood Loss, Surgical - prevention & control Child Child, Preschool elective orthopaedic surgery (EOS) Elective Surgical Procedures - methods Factor VIIa - therapeutic use haemophilia Hemophilia A - drug therapy Hemophilia B - drug therapy Hemostasis, Surgical - methods Humans inhibitors Male Orthopedic Procedures - methods plasma-derived activated prothrombin complex concentrates (pd-APCC) recombinant activated factor VII (rFVIIa) Recombinant Proteins - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!